Recall record at a glance
| Official record | F-0730-2014 |
|---|---|
| Category | Food Recalls |
| Classification | Class I |
| FDA record status | Terminated |
| Recalling firm | The New French Bakery |
| Report date | Dec 18, 2013 |
| Recall initiation date | Nov 13, 2013 |
| Quantity | 91 jars, 16 recovered at retail stores |
| Location | South San Francisco, CA, United States |
Official product description
Chocolate La Boulange Soft Caramel, Net WT. 8.4 oz. (238 g); Cooked in small batches in copper pots; all natural La Boulange South San Francisco, CA
Why the product was recalled
Firm discovered that 8.4 oz. jars of Hazelnut Jam were produced on 8/15/13 and were mislabeled as La Boulange Soft Caramel. the Hazelnut jam contains hazelnuts which were undeclared on the label.
Distribution information
20 retail locations in the San Francisco Bay area.
How to read the classification
FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Telephone.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.